---

---

sector : Transportation and warehousing    tags : Trial   

save search

---

Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 94.86% | O: 6.66% H: 7.43% C: 6.72%
sbi-100 glaucoma ocular bioscience hypertension trial

---

Skye Bioscience Receives IND Clearance for Phase 2 Clinical Trial of Nimacimab in Obesity and Chronic Kidney Disease
Published: 2024-01-09 (Crawled : 16:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 479.75% | O: -7.02% H: 29.11% C: 15.56%
SNY | News | $47.69 1.15% 1.13% 1.6M |

Health Technology

| -8.67% | O: 0.74% H: 0.0% C: 0.0%
obesity disease kidney bioscience clearance trial

---

Skye Bioscience Announces Positive Phase 1 Trial Results for SBI-100 Ophthalmic Emulsion, Its First-in-Class CB1 Agonist Being Developed for the Treatment of Glaucoma
Published: 2023-10-25 (Crawled : 14:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 482.16% | O: -0.31% H: 0.0% C: -23.0%
sbi-100 glaucoma agonist positive bioscience treatment trial results

---

Skye Bioscience Receives Clinical Site Approvals for Glaucoma Phase 2a Trial
Published: 2023-09-27 (Crawled : 15:30) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| Email alert Add to watchlist
glaucoma bioscience trial

---

Skye Bioscience Completes Production and Filling of Investigational Drug Material in Preparation for Phase 2a Glaucoma Clinical Trial
Published: 2023-07-06 (Crawled : 16:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 62814.8% | O: -9.87% H: 19.4% C: 19.4%
glaucoma drug bioscience trial

---

Skye Bioscience Completes Enrollment of Phase 1 Clinical Trial of Novel CB1R Agonist, SBI-100 Ophthalmic Emulsion
Published: 2023-06-12 (Crawled : 15:20) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 92813.91% | O: 0.0% H: 11.92% C: 5.3%
sbi-100 bioscience trial

---

Skye Bioscience Begins Dosing Fifth of Six Cohorts in Phase 1 Clinical Trial of Novel CB1R Agonist
Published: 2023-05-17 (Crawled : 14:20) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 96658.62% | O: 3.45% H: 3.33% C: -3.33%
six agonist bioscience trial

---

Skye Bioscience Doses Third Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
Published: 2023-03-07 (Crawled : 15:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 46666.67% | O: -9.67% H: 10.33% C: 7.01%
sbi-100 trial bioscience ophthalmic emulsion phase 1

---

Skye Bioscience Doses Second Cohort of Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
Published: 2023-02-13 (Crawled : 18:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 36153.23% | O: -4.91% H: 14.13% C: 0.54%
sbi-100 trial bioscience ophthalmic emulsion phase 1

---

Skye Bioscience Retains Lexitas Pharma Services as CRO for Phase 2 Trial of SBI-100 Ophthalmic Emulsion
Published: 2023-02-02 (Crawled : 16:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 36821.05% | O: 2.11% H: 36.6% C: 29.64%
sbi-100 pharma services trial bioscience phase 2 ophthalmic emulsion

---

Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
Published: 2023-01-27 (Crawled : 15:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 50007.14% | O: 3.57% H: 10.0% C: -1.72%
sbi-100 trial approval bioscience phase 2 ophthalmic emulsion

---

Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
Published: 2022-12-16 (Crawled : 16:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 103061.76% | O: -8.09% H: 27.2% C: 8.0%
sbi-100 trial bioscience ophthalmic emulsion phase 1

---

TSP CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Investors in the TuSimple Holdings (TSP) IPO to Contact the Firm's Attorneys, Securities Class Action Filed
Published: 2022-09-07 (Crawled : 14:00) - prnewswire.com
TSP | $0.25 -5.66% 3.96% 0 |

Transportation and Warehousing

| -96.54% | O: -1.11% H: 6.16% C: 5.88%
trial

---

TSP INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Investors in the TuSimple Holdings (TSP) IPO to Contact the Firm's Attorneys, Firm Investigating Possible Securities Law Violations
Published: 2022-08-03 (Crawled : 14:00) - prnewswire.com
TSP | $0.25 -5.66% 3.96% 0 |

Transportation and Warehousing

| -97.27% | O: -0.22% H: 7.89% C: 6.35%
trial

---

Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 37818.92% | O: -4.86% H: 7.1% C: 3.69%
research trial bioscience phase 1

---

Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
SKYE | $14.03 -5.27% -5.67% 140K |

Transportation and Warehousing

| 35782.35% | O: 0.0% H: 7.42% C: 0.26%
glaucoma drug trial phase 1 bioscience phase 2 phase 3

---

Sun Country Airlines to Participate in the 2022 Barclays Industrial Select Conference
Published: 2022-02-21 (Crawled : 20:00) - globenewswire.com
SNCY | $14.82 -1.53% -1.59% 330K |

Transportation and Warehousing

| -46.46% | O: -0.51% H: 0.98% C: -1.6%
air trial conference

---

Yellow Corporation to Present at Raymond James Diversified Industrials Conference
Published: 2021-08-18 (Crawled : 17:00) - globenewswire.com
YELL | $1.1 -29.03% -44.19% 8.1M |

Transportation and Warehousing

| -81.07% | O: -0.17% H: 2.24% C: -1.38%
trial conference presentation

---

Frontier Airlines to Participate in UBS Global Industrials and Transportation Virtual Conference
Published: 2021-06-03 (Crawled : 15:15) - globenewswire.com
ULCC | $6.72 -5.49% -5.8% 1.6M |

Transportation and Warehousing

| -68.98% | O: -0.88% H: 0.84% C: -5.22%
trial conference

---

Frontier Airlines to Participate in the Wolfe Research Transportation and Industrials Conference
Published: 2021-05-24 (Crawled : 16:00) - globenewswire.com
ULCC | $6.72 -5.49% -5.8% 1.6M |

Transportation and Warehousing

| -64.54% | O: 1.27% H: 3.23% C: 1.25%
research trial conference

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 26M |

AGBA | $2.97 137.6% 57.48% 66M |

Finance

EDBL | News | $6.59 75.27% 41.8% 2M |

ZAPP | $4.44 50.2% 33.12% 370K |

n/a

MTC | $2.24 43.59% 30.67% 6M |

Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M |

Finance

SHIM | $3.045 35.33% 26.23% 870K |

HKIT | $1.33 30.39% 24.16% 390K |

Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M |

Wholesale Trade

OST | $0.5 25.0% 21.88% 280K |

---

Your saved searches

---